- Home
- MMA vs COCP Comparison
MMA vs COCP Comparison
Compare MMA & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- COCP
- Stock Information
- Founded
- MMA 2013
- COCP 2006
- Country
- MMA Australia
- COCP United States
- Employees
- MMA N/A
- COCP N/A
- Industry
- MMA
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- COCP Health Care
- Exchange
- MMA Nasdaq
- COCP Nasdaq
- Market Cap
- MMA 15.9M
- COCP 15.4M
- IPO Year
- MMA 2024
- COCP N/A
- Fundamental
- Price
- MMA $0.78
- COCP $1.57
- Analyst Decision
- MMA
- COCP Strong Buy
- Analyst Count
- MMA 0
- COCP 1
- Target Price
- MMA N/A
- COCP $7.00
- AVG Volume (30 Days)
- MMA 175.0K
- COCP 13.0K
- Earning Date
- MMA 01-21-2025
- COCP 05-20-2025
- Dividend Yield
- MMA N/A
- COCP N/A
- EPS Growth
- MMA N/A
- COCP N/A
- EPS
- MMA N/A
- COCP N/A
- Revenue
- MMA $375,175.00
- COCP N/A
- Revenue This Year
- MMA N/A
- COCP N/A
- Revenue Next Year
- MMA N/A
- COCP N/A
- P/E Ratio
- MMA N/A
- COCP N/A
- Revenue Growth
- MMA 45.19
- COCP N/A
- 52 Week Low
- MMA $0.60
- COCP $1.12
- 52 Week High
- MMA $5.00
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- MMA N/A
- COCP 54.11
- Support Level
- MMA N/A
- COCP $1.44
- Resistance Level
- MMA N/A
- COCP $1.65
- Average True Range (ATR)
- MMA 0.00
- COCP 0.18
- MACD
- MMA 0.00
- COCP 0.01
- Stochastic Oscillator
- MMA 0.00
- COCP 57.76
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).